Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label repeatable on demand. Show all posts
Showing posts with label repeatable on demand. Show all posts

Tuesday, August 4, 2026

Neuroplasticity After Stroke: Clinical Evidence and Its Implication for Effective Rehabilitation Strategies

 You're NOT SOLVING THE PROBLEM! You're all fired for incompetence! How do you make neuroplasticity repeatable on demand?

Neuroplasticity After Stroke: Clinical Evidence and Its Implication for Effective Rehabilitation Strategies


Yun-Hee Kim,1, 2 Seyoung Shin,3 and Jinuk Kim1

Abstract

Stroke remains a major cause of long-term disability as it often leads to persistent motor deficits, which hinder functional recovery. Neuroplasticity is an important driver of poststroke recovery as it supports synaptic remodeling, network reorganization, and activity-dependent adaptation. This review outlines the neurobiological mechanisms of recovery, including Hebbian and homeostatic plasticity. It also discusses how intensive, task-specific rehabilitation leverages these processes. Technological innovations, such as robotic-assisted rehabilitation and sensor-based feedback, further enable high-dose, repetitive, and personalized training. In addition, adjunctive strategies, including pharmacological modulation, noninvasive brain stimulation, and stem cell therapies, which aim to enhance neuroplasticity, are highlighted. Despite their promise, these interventions show inconsistent efficacy, indicating the need for individualized approaches tailored to lesion characteristics, neurophysiological markers, and recovery stage. Future directions should emphasize the integration of biomarkers, neuroimaging, and precision neurotechnologies, together with multimodal combination therapies. These efforts are essential to establish adaptive rehabilitation protocols that can enhance both the consistency and the magnitude of functional recovery.

Highlights

  • • Neuroplasticity is essential to poststroke recovery and functional restoration.

  • • Intensive rehabilitation is an important element of experience-dependent plasticity.

  • • Multimodal therapies enhance recovery outcome but require individualized approaches.

More at link.

Friday, July 24, 2026

Engineers Redefined Light Delivery to Track Neural Firing

 Now your competent? doctor can get research going that captures the signals sent by one neuron to a neighbor to drop their current task and take on theirs. Figuring that out could finally make neuroplasticity repeatable on demand,

Engineers Redefined Light Delivery to Track Neural Firing

Summary: Researchers developed a two-photon imaging platform called FlatMux that captures real-time electrical voltage signals from nearly 200 neurons simultaneously in living brain tissue.

The team redesigned optical light delivery to overcome physical trade-offs between laser power, tissue heating, and signal sensitivity. By using an optical cavity to split laser beams into precisely timed pulses without mechanical raster sweeping, FlatMux maximizes fluorescence photon efficiency while reaching frame rates up to 2,000 frames per second at depths of 500 micrometers.

The system detects genetically encoded voltage indicators (GEVIs) with millisecond precision across multiple cortical layers, successfully capturing sub-threshold synaptic signals. This technology allows neuroscientists to map functional connectivity and observe parallel computation across distributed neural networks as animals engage in sensory behavior.

Key Facts

  • Unprecedented Speed and Scale: FlatMux records direct electrical activity from nearly 200 neurons simultaneously across single or multiple cortical layers at frame rates up to 2,000 Hz.
  • Deep Tissue Penetration: The platform captures millisecond voltage signals up to 500 micrometers deep in scattering cortical tissue of awake, head-fixed mice.
  • Efficient Optical Cavity Engineering: Instead of traditional mechanical laser sweeping, FlatMux splits a laser beam into non-overlapping pulses delivered at 150 million samples per second, minimizing tissue heating while maximizing photon yield per neuron.
  • Sub-Threshold Signal Detection: In high-sensitivity mode, FlatMux detects faint voltage fluctuations that precede action potentials, enabling optical mapping of synaptically connected, functional microcircuits.
  • Cell Type Identification: Direct voltage imaging via fluorescent signals allows researchers to simultaneously identify physical cell locations, cell-type classifications, and real-time functional roles without physical electrode insertion.

Source: Rockefeller University

The brain is a vast, densely interconnected network of neurons computing in parallel. Watching these computations unfold in real time could reveal how the brain processes sensation and guides behavior. But the electrical signals governing the network are fast, faint, and notoriously hard to capture in living tissue.

Now, a new study published in Nature Methods describes a two-photon imaging platform that captures electrical activity from almost 200 neurons at once, across cortical layers and at unprecedented depths and speeds, opening a window onto how information moves through living brain circuits.

By minimizing the amount energy needed to reliably detect the activity of a single neuron and devising a scalable strategy to optically scan laser pulses across the sample at a rate of 150 million samples per second, the platform, dubbed FlatMux, sets new benchmarks in the field, enabling recordings from nearly 200 neurons within one or several planes at once, at depths up to 500 micrometers, and at frame rates of up to 2,000 per second.  

With both the sensitivity and the speed that this tool offers, researchers can now begin mapping neurons that are functionally connected to and causally interact with one another, enabling a new understanding of how the brain’s wiring and function are giving raise to brain’s cognitive capabilities. Moreover, unlike methods using electrode probes, the direct imaging of electrical activity via fluorescence allows for simultaneous inference of the location and the cell types of recorded neurons.

“For a long time the field has been focused to understand the brain in terms of response properties of individual neuron. Our imaging platform makes it possible to instead investigate how various brain functions could be the result of information processing by a highly interconnected system where computation is distributed across large network of neurons,” says Alipasha Vaziri, head of the Laboratory of Neurotechnology and Biophysics at Rockefeller.

Densely interconnected

Existing imaging tools have been hampered by different limitations. As far as optical tools are concerned, when trying to capture the densely interconnected system of brain cells, scientists long relied on calcium imaging, which uses fluorescent sensors to track calcium surges associated with neurons firing. But calcium signals are only an indirect measurement of electrical activity.

In addition, they are much slower than the millisecond electrical impulses that brain cells use to communicate, so these techniques would miss key features of neural computation, including the signals that shape activity before a neuron fires (so-called sub-threshold responses).

In more recent years, researchers turned instead to genetically encoded voltage indicators, or GEVIs—fluorescent sensors embedded in cell membranes that report voltage directly. But GEVIs have their own challenges. Their signals are faint, about 100 times faster than calcium signals and notoriously difficult to capture deep in living brain tissue.  

Imaging them at depth requires two-photon microscopy, a laser-based technique that can peer into scattering tissue but brings its own hard physical limits: too little laser power produces unusable signals, while too much can heat tissue or destroy sensors. Traditional two-photon systems are also highly inefficient in how they deliver light, limiting how many neurons can be recorded and for how long.

Vaziri set out to overcome such limitations, devising a tool that better capture the complex nature of brain activity. “We needed to come up with a system that makes excitation as efficient as it can be,” Vaziri says. “By maximizing the fluorescent photons we get out for the excitation photons we put in, we are able to look at as many neurons as possible.”

Rethinking light

To accomplish this, Vaziri and colleagues would need to rethink light delivery itself. They built a custom two-photon imaging platform, called FlatMux, that utilizes an optical cavity. The new platform splits a laser beam into many precisely timed pulses, which are delivered to series of distinct, non-overlapping points in the tissue in a highly coordinated way.

This is in contrast to the traditional approaches that rely on a mechanically sweeping that results in laser pulses oversampling each sample region during a scan. Their approach does not only allow for faster scanning but also makes the system far more efficient, generating stronger signals from less light, while also reducing tissue heating and undesirable artefacts.

With FlatMux, researchers can image larger groups of neurons, deeper in the brain, and fast enough to capture the millisecond electrical events neurons use to communicate. Moreover, the design of the system is scalable, i.e. as GEVIs continue to improve FlatMux will be able to reallocate realized gains in energetic recourses to record from even larger neuronal populations while maintaining the same speed and without further increases in power.

The team then paired FlatMux with custom computational tools designed to distinguish true neural activity from background noise. Together, the hardware and software work as a single platform: one maximizes how much information can be extracted from every photon sent into the brain, while the other reconstructs the fleeting electrical signals hidden in that data.

Then, to test it in realistic conditions, the team used the system in awake mice running on a treadmill who were exposed to whisker stimulation, showing that the system could capture faint voltage signals during such stimulation as well as during spontaneous behavior.

The result was a system built not just to image more neurons, but to capture neural computation in action. And the payoff was dramatic. FlatMux recorded almost 200 neurons simultaneously, reached depths of 500 micrometers, captured activity at up to 2,000 frames per second, and even imaged two cortical layers at once, allowing researchers to watch signals move through the layered cortical circuitry in real time.

In a high-sensitivity mode, the system also detected signals too weak to trigger firing but critical for revealing the neurons that are synaptically coupled to one another, raising the possibility of mapping functional connections optically and in a high-throughput manner rather than one cell pair at a time.

With FlatMux, it may finally be possible to move beyond snapshots of isolated neurons to capturing computations as they unfold across distributed networks in real time. That could help researchers trace how signals move through circuits, study the coordinated activity underlying various behaviors such as decision-making, and potentially even transform the burgeoning field of connectomics. Its millisecond precision may also help researchers distinguish different kinds of brain cells by their electrical signatures, opening a new way to classify cell types by function.

“A lot of effort has been put into the goal of understanding the brain wiring diagrams of model organisms,” Vaziri says. “The FlatMux platform could be used to infer how neurons are synaptically connected.”

More broadly, FlatMux points toward a shift in neuroscience, from sampling fragments of activity to capturing how living brain circuits compute in real time. “The brain as not only a biological organ but also an information processing system, and I’ve always been excited about figuring out its underlying computational principles,” Vaziri says.

“When we build these kinds of tools, it’s not just about overcoming an engineering challenge. It’s about enabling neuroscience to ask deeper questions about how the brain computes.”

Key Questions Answered:

Q: Why is voltage imaging harder to perform than calcium imaging?

A: Calcium signals are slow, indirect surrogates for neural firing that unfold over hundreds of milliseconds. Direct voltage signals happen in 1 to 2 milliseconds, requiring recording speeds roughly 100 times faster. Furthermore, genetically encoded voltage indicators (GEVIs) yield fainter fluorescent signals, making deep-tissue detection exceptionally difficult without burning brain tissue.

Q: How does FlatMux overcome tissue heating caused by high-power lasers?

A: Traditional two-photon microscopes use mechanical mirrors that sweep lasers across tissue, oversampling regions and dumping excess energy that can heat tissue. FlatMux utilizes a custom optical cavity to split laser pulses into discrete, non-overlapping points in a coordinated sequence, getting the maximum number of fluorescent photons back for every excitation photon sent in.

Q: What is sub-threshold voltage detection and why does it matter?

A: Sub-threshold responses are tiny electrical fluctuations in a neuron that occur before it reaches the threshold required to fire an action potential. Detecting sub-threshold signals reveals how input signals are integrated across synaptically connected neurons, shedding light on functional circuit wiring.

Editorial Notes:

  • This article was edited by a Neuroscience News editor.
  • Journal paper reviewed in full.
  • Additional context added by our staff.

About this neurotech research news

Author: Katherine Fenz
Source: Rockefeller University
Contact: Katherine Fenz – Rockefeller University
Image: The image is credited to Neuroscience News

Original Research: Open access.
“A versatile platform for two-photon neuronal population voltage imaging across cortical depths” by Jingkun Guo, Kevin Barber, M. Agustina Frechou, Sihao Lu, Jeff Demas, David Chen, Shuyuan Yang, Alex James McDonald, Michelle Ann Land, François St-Pierre & Alipasha Vaziri. Nature Methods
DOI:10.1038/s41592-026-03158-y

Tuesday, July 21, 2026

Neuroplasticity in Post-Stroke Adults: Mechanisms, Modulators, and Rehabilitation Strategies: A Literature Review

 You've proven you know nothing about why a neuron gives up its' current function and takes on a neighbor's function! Figuring that out would make neuroplasticity repeatable on demand!

Neuroplasticity in Post-Stroke Adults: Mechanisms, Modulators, and Rehabilitation Strategies: A Literature Review

 Jinal Choudhari, MD 
Namita Ruhela, Ph,D.
Marti Echols, Ph,D.

Abstract

Cerebrovascular stroke remains a leading cause of long-term disability and motor impairment worldwide. Although the adult brain possesses less regenerative capacity than the pediatric nervous system, it retains a significant ability to reorganize neural networks through neuroplasticity. Understanding the biological mechanisms that govern post-stroke neuroplasticity is essential for optimizing recovery and rehabilitation outcomes. This narrative review synthesizes current evidence on the cellular and molecular pathways underlying neuroplastic changes following stroke and examines key modulators, including epigenetic regulation, neuroinflammation, sleep, environmental enrichment, and pharmacological interventions. Relevant peer-reviewed studies, systematic reviews, and preclinical investigations were analyzed to provide a comprehensive overview of the field. Current evidence suggests that adult post-stroke neuroplasticity is a dynamic and therapeutically modifiable process. Multimodal rehabilitation programs, targeted epigenetic therapies, anti-inflammatory strategies, and emerging technologies such as stem cell therapy and optogenetics represent promising avenues for enhancing neurological recovery, particularly during the critical 3-6 month period following stroke.

More at link.

Tuesday, February 24, 2026

Construction of biomimetic nanomedicine delivery system based on biomedical materials for treating brain diseases: A review

 Our researchers can use this whenever they come up with methods to make neuroplasticity and neurogenesis repeatable on demand.

Construction of biomimetic nanomedicine delivery system based on biomedical materials for treating brain diseases: A review


https://doi.org/10.1016/j.ijbiomac.2026.151033Get rights and content

Abstract

Brain diseases are often characterized by a high mortality rate and high treatment difficulty, posing significant challenges to human healthcare. However, due to the presence of the blood-brain barrier (BBB), which separates brain blood vessels from brain tissue, the delivery efficacy of traditional delivery systems is limited. This makes it difficult to deliver drugs effectively to the affected areas, thereby severely limiting their therapeutic efficacy in treating these brain diseases. Recently, biomimetic drug delivery systems, particularly those based on biomaterials, have revolutionized this landscape. These systems utilize natural active substances or endogenous materials, which, when combined with therapeutic drug molecules or imaging agents, leverage their inherent biological properties to achieve effective brain targeting and drug accumulation. Compared with traditional drug delivery systems, they offer advantages in terms of good biocompatibility, prolonged in vivo circulation, BBB permeability, high bioavailability, and inherent targeting capabilities. Moreover, they can achieve “invisible” drug delivery. In this review, we discuss the current state of research and application scenarios of drug delivery systems based on different biomaterials for achieving brain drug delivery across the BBB. We summarize the mechanisms and design concepts of such research and explore the possibility of combining the design of such drug delivery systems with other technologies, such as gene therapy and immunotherapy. Furthermore, prospects and emerging challenges will be highlighted. Given the lack of comprehensive reviews in this emerging field, this review is likely to open new opportunities for the treatment of brain disorders.

Introduction

As the trend of population aging continues to intensify, the incidence of brain diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), cerebral stroke (CVA), encephalitis, and brain tumors have been steadily increasing year by year, making them one of the most significant threats to human health today. Currently, the most effective treatment plan for brain diseases remains chemical drug therapy. However, due to the blood-brain barrier (BBB), it is incredibly challenging to achieve effective drug delivery to the brain via non-invasive methods from peripheral blood. As a semi-permeable membrane biological barrier [1], the BBB blocks almost all macromolecular drugs and 98% of small molecule drugs from entering the brain parenchyma, which makes the drug molecules for treating brain diseases have a low penetration rate through the BBB, seriously hindering the non-invasive drug treatment of the disease [2].
With the development of nanotechnology, the design of nanomedicine delivery systems has emerged as an effective strategy for transporting drugs to diseased areas. An increasing number of delivery carriers, such as polymer carriers, nanogels, liposomes, biological carriers, and inorganic nanomaterials, are being used in nanomedicine delivery. These carriers often play a role in protecting and increasing the drug loading capacity, and can also reduce drug degradation and clearance. However, researchers have also found that, regardless of whether these nano-like particles cross the BBB through passive diffusion or active transport, the overall effect is minimal. Nanoparticles that adopt passive diffusion usually accumulate and release drugs at the pathological site by enhancing permeability and the retention effect (EPR) [3]. However, the passive delivery method is prone to off-target effects, resulting in toxic side effects caused by drug accumulation in other organs and tissues in the body. Additionally, these nanoparticles in the blood are readily cleared by phagocytic cells, resulting in a relatively small amount of drug reaching the target site [4]. Moreover, the active delivery method locates and binds to diseased cells or their surrounding microenvironment via specific ligand functionalization or self-targeting carriers (Fig. 1). However, issues regarding the safety, stability, and biocompatibility of the functionalized nanomedicine delivery systems remain limiting factors for effective drug delivery. They may even trigger unnecessary immune responses [5]. Therefore, to achieve drug delivery for brain diseases, more advanced drug delivery systems need to be developed.
The biomimetic nanomedicine delivery system has attracted increasing attention in recent years due to its excellent biocompatibility and its inherent multi-functional integration capability. This type of system can simulate the structure or function of living organisms and has strategies for delivering drugs used to treat brain diseases. They are mainly divided into two types: one is a design scheme based on artificially synthesized biomimetic materials with functions, such as hydrogels with excellent mechanical strength. The other is a design scheme based on natural biomaterials, such as immune cells loaded with nanomedicines and transported via chemical or biological binding. A biomimetic nanomedicine delivery system based on biomaterials is one created from the structure and function of natural biological organisms. These biomimetic carriers can retain or mimic the natural characteristics of cells, viruses, and endogenous substances [6]. Compared to other nanomedicine delivery systems, biomaterials can endow nanomedicines with unique biological activity, thereby improving biocompatibility and reducing immunogenicity. These endogenous carriers are not readily cleared by the body's endothelial reticular network, allowing nanoparticles to circulate for extended periods and exhibit good in vivo degradability. Many biomimetic carriers based on biomaterials have natural targeting properties for the target without modification, for example, immune cells themselves can cross the BBB and tend to the brain inflammation and tumor areas (Scheme 1). Compared with drug delivery systems based on other materials, the biomimetic nanomedicine delivery system based on biological materials not only serves as a drug-loading platform for the target site, but also retains the inherent active components and characteristics of the biological source, resulting in lower in vivo toxicity. It can carry therapeutic drugs across the BBB (Scheme 2) and adopt a synergistic method to treat brain diseases [7]. For example, researchers can adopt Trojan horse [8], hitchhiking [9], and backpack strategies [10] based on cells and their derivatives to expand the drug loading capacity and the surface modifiable area, creating a vast design space for surface modification, functionalization modification, regulation of biological activity, extension of in vivo circulation time, and improvement of biocompatibility. This article, based on different biomimetic carriers as the framework, systematically discusses the latest research progress of delivery systems using cell membranes, living cells, bacteria, exosomes, viruses, albumin, and lipoprotein carriers for treating brain diseases. Starting from the design ideas of drug loading and delivery systems, it critically discusses the advantages and disadvantages of these biomimetic carriers in constructing delivery systems. The innovation and replicability of these brain-targeted delivery and disease visualization strategies are summarized. By integrating insights from materials science and clinical medicine, this review aims to guide the research and development of biomimetic nanomedicine delivery systems based on biological materials for treating brain diseases.

Access through your organization

Tuesday, January 6, 2026

Wireless EEG tracks neuroplasticity in trials

 So, we now can exactly identify the signals between neurons that tell one neuron to drop their use and take on a neighboring neuron's use! That could then make neuroplasticity repeatable on demand. If your doctor and hospital aren't pushing for further research on this; THEY ARE COMPLETELY FUCKING INCOMPENT!

Do you prefer your doctor, hospital and board of director's incompetence NOT KNOWING? OR NOT DOING?

Wireless EEG tracks neuroplasticity in trials

Researchers validated a wireless EEG method to measure neuroplasticity, offering a non-invasive way to track how the brain responds to new treatments.

The approach could provide an objective readout of brain response to therapies for psychiatric and neurodegenerative conditions.

Neuroplasticity is the brain’s ability to reorganise its connections after experience, injury or disease, for example by forming new pathways to aid recovery.

The research, conducted by Cumulus Neuroscience, used visual evoked potential (VEP) modulation to mark neuroplasticity.

VEPs are brain signals produced in response to visual patterns.

The method was tested in two US-based clinical trials involving 50 healthy participants.

Brian Murphy, co-founder and chief scientific officer at Cumulus Neuroscience, said: “This study demonstrates that it is possible to measure neuroplasticity reliably in real-world clinical environments using a non-invasive, low-burden, scalable approach.

“Our findings open the door to incorporating objective plasticity measures into early-phase CNS drug development, which could accelerate progress in treating neuropsychiatric and neurodegenerative disorders.”

Conventional EEG assessments are time-consuming and burdensome, which has limited their use in trials.

The new approach uses a quick set-up dry EEG headset with frequency-domain analyses to extract precise measures.

Dr David Walling, chief clinical officer for CenExel-CNS and principal investigator for the study, said: “The ability to capture valid VEPs in clinical studies with easy-to-deploy technology and short sessions has the potential to transform how we assess the efficacy of new therapies in this space.

“Historically, we have not had a way to directly measure neuroplasticity outside of animal models which require invasive techniques.

“We can now integrate non-invasive VEP measures into clinical study workflows, providing sponsors with objective biomarkers of target engagement and treatment effects early in development.”

Tuesday, October 7, 2025

Neuroplasticity in Recovery after Stroke: Mechanisms and Therapeutic Targets

Nothing here tells us EXACTLY HOW TO MAKE NEUROPLASTICITY REPEATABLE ON DEMAND!  Absolutely useless! 

Neuroplasticity in Recovery after Stroke: Mechanisms and Therapeutic Targets


Authors

  • Mohammed Ahmed MustafaDepartment of Biology, College of Education, University of Samarra, Iraq

Keywords: 

Neuroplasticity; Stroke recovery; Rehabilitation; Motor Reorganization; Constraint-Induced Movement Therapy (CIMT); Noninvasive Brain Stimulation; Virtual Reality

Abstract

Background: Stroke remains a leading cause of death and long-term disability globally, with traditional rehabilitation approaches primarily focusing on compensatory strategies rather than neural repair mechanisms.

Objective: This narrative review synthesizes current evidence on neuroplasticity mechanisms underlying stroke recovery and evaluates therapeutic interventions that harness the brain's reorganization capacity to improve functional outcomes.

Methods: A comprehensive literature search was conducted using PubMed, Embase, and Cochrane Library databases for English-language studies published between 2000 and April 2023. Search terms included "stroke rehabilitation," "neuroplasticity," "motor recovery," and specific interventions.

Results: Key neuroplastic mechanisms—including synaptic plasticity, dendritic remodeling, cortical reorganization, neurogenesis, and axonal sprouting—underlie both spontaneous and therapy-induced recovery. Evidence-based interventions leveraging these mechanisms include constraint-induced movement therapy (CIMT), physical exercise, non-invasive brain stimulation, virtual reality training, brain-computer interfaces, and emerging cell-based therapies. Recovery outcomes are significantly influenced by individual factors (age, genetics, stroke characteristics) and contextual factors (rehabilitation timing, intensity, resource availability).

Conclusions: Neuroplasticity-based rehabilitation represents a paradigm shift from compensatory to restorative approaches. Future directions emphasize early, intensive, personalized interventions combining behavioral, neuromodulatory, and pharmacological strategies to optimize functional recovery and quality of life for stroke survivors.

Tuesday, September 30, 2025

Neuroplasticity-Based Physiotherapy Approaches in Stroke Rehabilitation: A Systematic Review

But you KNOW NOTHING ABOUT MAKING NEUROPLASTICITY REPEATABLE ON DEMAND. Useless. Creating EXACT PROTOCOLS IS NEEDED! Where the fuck are they?

We don't SPECIFICALLY know why a neuron gives up its' current job and takes on a neighbors.  Thus nothing on neuroplasticity is scientifically repeatable on demand. So, DEMAND your doctor give you EXACT PROTOCOLS to use. Don't allow your doctor to give you generalities or guidelines. 

The latest useless crapola here:

 Neuroplasticity-Based Physiotherapy Approaches in Stroke Rehabilitation: A Systematic Review


https://doi.org/10.21203/rs.3.rs-7696362/v1

This work is licensed under a CC BY 4.0 License

Background: Stroke is a leading cause of adult disability worldwide, with motor impairments being the most common sequel. Neuroplasticity  the brain’s capacity to reorganize neural networks underpins functional recovery and is enhanced by specific physiotherapy interventions.

Objective: This systematic review aimed to evaluate the effectiveness of neuroplasticity-based physiotherapy approaches in improving motor recovery and functional independence among stroke survivors.

Methods: A comprehensive search was conducted across PubMed, Scopus, PEDro, and Web of Science for randomized controlled trials (RCTs) published between January 2010 and August 2025. Eligible studies included adult stroke patients undergoing neuroplasticity-based physiotherapy interventions such as constraint-induced movement therapy (CIMT), mirror therapy, task-specific training, robotic-assisted therapy, and virtual reality. Two reviewers independently screened studies, extracted data, and assessed methodological quality using the PEDro scale. The PRISMA guidelines were followed.

Results: Twenty-three RCTs (n = 1,465 participants) met the inclusion criteria. CIMT and task-specific training consistently demonstrated significant improvements in upper limb motor function and activities of daily living (ADL). Mirror therapy showed moderate evidence for upper limb recovery, particularly in subacute stroke. Robotic-assisted therapy and virtual reality yielded positive but heterogeneous results, with effectiveness influenced by stroke chronicity and intervention intensity. Risk of bias was moderate, mainly due to small sample sizes and lack of blinding.

Conclusion: Neuroplasticity-based physiotherapy approaches are effective in enhancing motor recovery after stroke, especially CIMT and task-specific training. However, heterogeneity in study protocols limits definitive conclusions. Larger, multicenter RCTs with standardized protocols are recommended